<?xml version="1.0" encoding="UTF-8"?>
<p id="Par25">To the present, there is only one retrospective study suggesting that COVID-19 patients with hypertension and already treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, showed better clinical outcome with respect to patients treated with other antihypertensive drugs [
 <xref ref-type="bibr" rid="CR36">36</xref>].
</p>
